Literature DB >> 14713837

Evolution of the treatment of vesicoureteral reflux in Spain.

Jose M Moran Penco1, Andre Gomez Fraile, Jorge Rodríguez Alarcon, Francisco Garcia Merino, Diego Vela, Santiago Sanjuán Rodriguez, Aldolfo Aransay Brantot.   

Abstract

PURPOSE: We determined the changes in the treatment of vesicoureteral reflux (VUR) at children's hospitals in Spain as well as the long-term results of endoscopic treatment (ET) with polytetrafluoroethylene, namely with STING (subureteral polytetrafluoroethylene injection).
MATERIALS AND METHODS: A survey was performed of all pediatric urology units in Spain to determine changes in the diagnosis and treatment of VUR in the last 10 years. Also, a conjoint study was made of STING case records at 5 Spanish hospitals where there is expertise in the technique.
RESULTS: The response rate was 34 of 44 cases (78%). The most significant changes were the introduction of urodynamics and the progressive establishment of ET as a substitute for open surgery and prolonged medical treatment. At more than 90% of the units ET is now done with different materials with a cure rate of 75% after 1 injection and a low index of complications. The results of the STING study in 2,035 refluxing ureters showed a cure rate of about 90% for 2 or 3 injections for grades I to IV reflux and just under 70% for grade V. Also, the cure rate for complex reflux was 60% and the index of complications was less than 1.2% with some intravesical migration.
CONCLUSIONS: There have been many changes in the approach to VUR with an increasing use of urodynamics and ET. Since the long-term results of STING are reliable and no long-term complications have been observed, polytetrafluoroethylene appears to be the product with the best quality/price ratio for use in ET. However, it is being replaced.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14713837     DOI: 10.1097/01.ju.0000108386.82067.cf

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  Endoscopic subureteral injection treatment with calcium hydroxylapatite in primary vesicoureteral reflux.

Authors:  Bilal Eryildirim; Fatih Tarhan; Uğur Kuyumcuoğlu; Erkan Erbay; Gökhan Faydaci
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

2.  Role of the Teflon deposit in the recurrence of vesicoureteral reflux.

Authors:  Zsolt Oberritter; Reka Somogyi; Zsolt Juhasz; Andrew B Pinter
Journal:  Pediatr Nephrol       Date:  2008-01-16       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.